Clinical Trial

NBTXR3 With Radiation Therapy Alone for Locally-advanced Non-small Cell Lung Cancer

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
This is a single institution, single arm phase I/II study of NBTXR3 with radiation therapy for stage I-III advanced non-small cell lung cancer patients who are not candidates for chemotherapy or surgical resection.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-10-31; most recent amendment 2026-03-31.
Status change: Not Yet Recruiting → Recruiting 2026-03-31
Trial Details
NCT Number NCT07224152
Lead Sponsor M.D. Anderson Cancer Center
Collaborators: Nanobiotix
Conditions Locally-Advanced Non-Small Cell Lung Cancer
Enrollment 40 participants
Start Date 2026-03-27
Primary Completion 2028-08-30 (estimated)
Study Completion 2030-08-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-06